DRUG LISTING FOR CLEAR-N-SMOOTH ULTRAMAX LOTION

Manufacturer
Hawknad Manufacturing Industries, Inc.
Effective date
2015-02-17
Label type
COSMETIC
Version
1
Source
legacy-cache
Hydrated at
2026-08-02 01:32:53

Label at a glance#

ProductClear-N-Smooth UltraMax
Active ingredientHYDROQUINONE
Label structure6 sections

Indications and uses

Lightens dark discolorations in the skin such as freckles, age and liver spots Contains a sunscreen to help prevent darkening from reoccurring

Label contents#

Full prescribing information#

FRONT OF LABEL

DESCRIPTION SECTION

Clear-N-Smooth UltraMax

Skin Lightening Lotion

with Vitamin E and Sunscreen

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Hydroquinone -2.0 %, Purpose - Skin Bleaching Agent

Octinoxate - 2.5%, Purpose - Sunscreen

USES

INDICATIONS & USAGE SECTION

  • Lightens dark discolorations in the skin such as freckles, age and liver spots
  • Contains a sunscreen to help prevent darkening from reoccurring

WARNINGS AND PRECAUTIONS SECTION

For external use only

Do not use

  • On children under 12 years of age unless directed by a doctor
  • This product is not for use in the prevention of sunburn

When using this product

  • Avoid contact with eyes
  • Some users of this product may experience a mild skin irritation.  If irritation becomes severe, stop use and consult a doctor.

INSTRUCTIONS FOR USE SECTION

  • Adults: Apply a small amount as a thin layer on the affected area twice daily, or use as directed by a doctor.  If no improvement is seen after 3 months of treatment, use of the product should be discontinued. Lightening effect of this product may not be noticeable when used on very dark skin.
  • Children under 12 years of age: do not use unless directed by a doctor
  • Sun exposure should be limited by using a sunscreen agent, a sun blocking agent, or protective clothing to cover bleached skin after treatment is completed in order to prevent darkening from reoccurring.

INACTIVE INGREDIENT SECTION

ascorbic acid, cetyl alcohol, citirc acid, chamomile, diazolidinyl urea, dimethicone, disodium EDTA, fragrance, glyceryl stearate, green tea extract, hydroxyethyl cellulose, isopropyl myristate, lanolin alcohol, licorice extract, methylparaben, propylparaben, mineral oil, peg-100 stearate, propylene glycol, sodium metabisulfite, stearyl alcohol, stearyl stearate, tocopherol acetate, water. 

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
HYDROQUINONEACTIVE INGREDIENTXV74C1N1AE1
HYDROQUINONEACTIVE MOIETYXV74C1N1AE1
ALPHA-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L01
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSL1
ASCORBIC ACIDINACTIVE INGREDIENTPQ6CK8PD0R1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN1
CHAMOMILEINACTIVE INGREDIENTFGL3685T2X1
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW41
DIMETHICONE 350INACTIVE INGREDIENT2Y53S6ATLU1
EDETATE SODIUMINACTIVE INGREDIENTMP1J8420LU1
ETHYLHEXYL PALMITATEINACTIVE INGREDIENT28659933091
GLABRIDININACTIVE INGREDIENTHOC5567T411
GLYCERYL MONOSTEARATEINACTIVE INGREDIENT230OU9XXE41
GLYCERYL STEARATE SEINACTIVE INGREDIENTFCZ5MH785I1
HYDROXYETHYL CELLULOSE (280 MPA.S AT 2%)INACTIVE INGREDIENT12VCE9HR9E1
ISOPROPYL MYRISTATEINACTIVE INGREDIENT0RE8K4LNJS1
LANOLIN ALCOHOLSINACTIVE INGREDIENT884C3FA9HE1
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T1
MINERAL OILINACTIVE INGREDIENTT5L8T28FGP1
OCTINOXATEINACTIVE INGREDIENT4Y5P7MUD511
PEG-100 STEARATEINACTIVE INGREDIENTYD01N1999R1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V31
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH1
SINECATECHINSINACTIVE INGREDIENTT432289GYZ1
SODIUM METABISULFITEINACTIVE INGREDIENT4VON5FNS3C1
STEARYL ALCOHOLINACTIVE INGREDIENT2KR89I4H1Y1
STEARYL STEARATEINACTIVE INGREDIENT5WX2EGD0DK1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 28 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
76445-049776445-0497-6

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 27 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 495 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
MINERAL OILMINERAL OILT5L8T28FGPOINTMENT / AURICULAR (OTIC)NAExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHLIQUID / TOPICAL0.1 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / OPHTHALMIC0.09 %w/vExact identifier — unii candidate
61 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, EXTENDED RELEASE / ORAL0.17 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / VAGINAL750 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / RECTAL271 mgExact identifier — unii candidate
68 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLGRANULE, FOR SUSPENSION / ORAL30 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CSYSTEM / TOPICAL1 mgExact identifier — unii candidate
43 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSSYSTEM / TRANSDERMAL113 mgExact identifier — unii candidate
18 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3ELIXIR / ORAL9306 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / AURICULAR (OTIC)56.55 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHPOWDER / ORALNAExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET, EXTENDED RELEASE / ORAL0.12 mgExact identifier — unii candidate
68 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION / SUBMUCOSAL5 mgExact identifier — unii candidate
43 equally ranked IID candidates
GLYCERYL MONOSTEARATEGLYCERYL MONOSTEARATE230OU9XXE4TABLET, DELAYED RELEASE / ORAL6 mgExact identifier — unii candidate
21 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LOTION, AUGMENTED / TOPICAL2070 mgExact identifier — unii candidate
81 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YOINTMENT / TOPICAL569 mgExact identifier — unii candidate
12 equally ranked IID candidates
ASCORBIC ACIDASCORBIC ACIDPQ6CK8PD0RSUPPOSITORY / RECTAL3 mgExact identifier — unii candidate
25 equally ranked IID candidates
ASCORBIC ACIDASCORBIC ACIDPQ6CK8PD0RSYRUP / ORAL200 mgExact identifier — unii candidate
25 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSYSTEM / TOPICAL21 mgExact identifier — unii candidate
68 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CSYSTEM / IONTOPHORESIS1 mgExact identifier — unii candidate
43 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / TOPICAL0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION / RECTAL904 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / INFILTRATION0.35 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL / TOPICAL19.2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION / INTRACARDIAC0.09 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCREAM / TOPICAL120 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION/ DROPS / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TPOWDER, FOR SOLUTION / ORAL126 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCONCENTRATE / ORAL12 mgExact identifier — unii candidate
79 equally ranked IID candidates
ASCORBIC ACIDASCORBIC ACIDPQ6CK8PD0RCONCENTRATE / ORAL6 mg/1mlExact identifier — unii candidate
25 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / RECTAL0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR12 mgExact identifier — unii candidate
43 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPSYSTEM / TOPICAL654.36 mgExact identifier — unii candidate
30 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TJELLY / NASAL250 mgExact identifier — unii candidate
79 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION / INTRAMUSCULAR27.5 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / AURICULAR (OTIC)10 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET / ORAL0.2 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TDROPS / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
79 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / TOPICAL4.35 %w/vExact identifier — unii candidate
61 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLOIL / TOPICAL2 mgExact identifier — unii candidate
61 equally ranked IID candidates
ASCORBIC ACIDASCORBIC ACIDPQ6CK8PD0RINJECTION / INTRACAVITARY5 mgExact identifier — unii candidate
25 equally ranked IID candidates
ASCORBIC ACIDASCORBIC ACIDPQ6CK8PD0RCAPSULE, DELAYED RELEASE / ORAL12 mgExact identifier — unii candidate
25 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4974 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION / SOFT TISSUE0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
MINERAL OILMINERAL OILT5L8T28FGPTABLET, DELAYED RELEASE / ORAL5.67 mgExact identifier — unii candidate
30 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCAPSULE, EXTENDED RELEASE / ORAL0.22 mgExact identifier — unii candidate
68 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CSOAP / TOPICAL0.36 %w/wExact identifier — unii candidate
43 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TGEL / VAGINAL8 mgExact identifier — unii candidate
79 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TCAPSULE, EXTENDED RELEASE / ORAL2 mgExact identifier — unii candidate
79 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLAEROSOL / TOPICAL0.08 %w/wExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / INTRAVENOUS0.13 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
ASCORBIC ACIDASCORBIC ACIDPQ6CK8PD0RSUSPENSION, EXTENDED RELEASE / ORAL6 mgExact identifier — unii candidate
25 equally ranked IID candidates
STEARYL ALCOHOLSTEARYL ALCOHOL2KR89I4H1YLOTION / TOPICAL1140 mgExact identifier — unii candidate
12 equally ranked IID candidates
ISOPROPYL MYRISTATEISOPROPYL MYRISTATE0RE8K4LNJSSUSPENSION / AURICULAR (OTIC)0.02 %w/wExact identifier — unii candidate
18 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 18 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NU-DERM BLENDER Skin Lightener and BlendingHYDROQUINONEObagi Cosmeceuticals LLCe5c450af-958e-41e3-9c2f-fda76b3596f52026-11-09Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
ZO Skin Health Pigment Control plus Brightening Creme Hydroquinone plus Vitamin CHYDROQUINONEZO Skin Health, Inc.d7bfa71b-ddce-437e-abf9-2837af82c54d2026-10-09WarningsName fallback
generic name: HYDROQUINONE
ZO Skin Health Pigment Control Creme HydroquinoneHYDROQUINONEZO Skin Health, Inc.83e34a75-d20c-43ab-be31-f8fcafec46d02026-10-09WarningsName fallback
generic name: HYDROQUINONE
ZO Skin Health Pigment Control Plus Blending Creme HydroquinoneHYDROQUINONEZO Skin Health, Inc.c29cbc80-cb97-42d0-b796-ee487b0e85c52026-10-09WarningsName fallback
generic name: HYDROQUINONE
HYDROQUINONE 4%HYDROQUINONEAcella Pharmaceuticals, LLC595dfc50-ee6f-41b5-ab5b-4c293aee342b2026-07-10Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
ZO Skin Health Pigment Control Program Plus HydroquinoneHYDROQUINONEZO Skin Health, Inc.377e151e-ee50-4488-9cc9-3169794e385e2026-04-14Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
Hydroquinone 4%HYDROQUINONEBryant Ranch Prepackba2b7504-17bb-4b9e-8db1-937f83d75a032026-03-17Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
Hydroquinone 4%HYDROQUINONENivagen Pharmaceuticals, Inc.7844c308-e0a2-42e7-bd28-f68a59ebca832026-01-20Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
hydroquinoneHYDROQUINONEMarlex Pharmaceuticals, Inc.be22c3e0-8760-1568-e053-2995a90a112a2025-11-13Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
OBAGI C RX system C CLARIFYING SERUMHYDROQUINONEObagi Cosmeceuticals LLC9ff4f617-b8d3-46d6-8ddb-41088dd8f2262025-01-01Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
HYDROQUINONE 4%HYDROQUINONEAkron Pharma Inccbec45c9-4adb-4473-8c09-b1217d0f8ebc2024-09-25Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
Hydroquinone 4%HYDROQUINONESOHM, Inc.47f0cbfb-b73b-4572-95d2-992c7382df3a2023-06-05Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
Hydro-QHYDROQUINONEDermavance Pharmaceuticals486781be-498a-49b4-9a80-2dfd02f5e3582023-01-12Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
HydroquinoneHYDROQUINONEWestminster Pharmaceuticals, LLCdc72c0b2-4505-4dcf-8a69-889cd9f416932022-12-14Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
OLIVIA QUIDO BLEMISH ERASERHYDROQUINONEO Skin Care LLCdfc742ae-41b5-d64a-e053-2995a90a1a8f2022-06-05Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
Hydroquinone creamHYDROQUINONEAPNAR PHARMA LPced62618-e87d-12b9-e053-2a95a90a30132021-10-21Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN CHYDROQUINONEObagi Cosmeceuticals LLC18803dfb-5b9c-48cd-a838-519c8bac33612020-06-02Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE
Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and EHYDROQUINONEObagi Cosmeceuticals LLC81e2e734-01fe-4568-903a-92993bf408872020-06-01Warnings, Adverse reactionsName fallback
generic name: HYDROQUINONE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.